Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Riedell
Impact of Body Mass Index on Incidence of Febrile Neutropenia and Treatment-Related Mortality in United States Veterans With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone
British Journal of Haematology
Hematology
Related publications
Role of Radiotherapy in Diffuse Large B‐cell Lymphoma in Advanced Stages on Complete Response After Administration of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab
Precision Radiation Oncology
Accept: A Phase Ib/Ii Combination of Acalabrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop) for Patients With Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
CD5-positive Diffuse Large B-Cell Lymphoma Showing Prominent Intra-Sinusoidal Infiltration in the Bone Marrow, Successfully Treated With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone in Combination With Rituximab
Tenri Medical Bulletin
A Phase II Study of Ibrutinib in Combination With Rituximab-Cyclophosphamide-Doxorubicin Hydrochloride-Vincristine Sulfate-Prednisone Therapy in Epstein-Barr Virus-Positive, Diffuse Large B Cell Lymphoma (54179060LYM2003: IVORY Study): Results of the Final Analysis
Annals of Hematology
Medicine
Hematology
A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma
British Journal of Haematology
Hematology
The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis
Current Biomarker Findings
Biochemistry
Clinical Biochemistry
Pegylated Liposomal Doxorubicin Combined With Cyclophosphamide, Vincristine/Vindesine, and Prednisone in Patients With Aggressive T-Cell Lymphoma: Preliminary Results of Aphase Ii Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
Journal of Clinical Medicine Research
